By Prosper Mene
In a major development that could reshape how women’s health is understood and managed across Nigeria and beyond, the condition long known as Polycystic Ovary Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS).
The change, announced on May 12, 2026, follows 14 years of global research and collaboration involving experts, patients, and over 50 professional organizations. It was detailed in a major paper published in The Lancet and endorsed by leading bodies including the Endocrine Society.
Why the Name Change Matters
The old name, PCOS, focused heavily on “polycystic” ovaries — small, immature follicles visible on ultrasound. However, many women with the condition do not have cysts at all, leading to frequent misdiagnosis or dismissal of symptoms, especially in resource-limited settings.
PMOS better reflects the condition’s true nature:
Polyendocrine: Involves multiple hormones beyond just the ovaries.
Metabolic: Highlights insulin resistance, energy processing issues, and increased risks for type 2 diabetes, obesity, high blood pressure, and cardiovascular disease.
Ovarian: Retains focus on reproductive impacts like irregular periods and infertility.
This is not merely cosmetic. The rename aims to drive more holistic diagnosis and care, addressing the full spectrum of symptoms rather than treating fragmented issues like acne at a dermatologist, weight at a dietitian, or infertility at a fertility clinic.
Impact on Nigerian Women
In Nigeria, where PCOS/PMOS is a leading contributor to infertility, the condition affects a significant portion of women of reproductive age. Studies report prevalence rates ranging from about 6–18% depending on criteria and population, with higher figures (up to 16–27%) among women seeking infertility care.
Many Nigerian women experience delayed or missed diagnoses. Symptoms such as irregular periods, unexplained weight gain (even in slim women), acne, hirsutism, hair thinning, and mood changes are often attributed to stress, “spiritual attacks,” lifestyle, or simply dismissed. A 2025 study highlighted low awareness levels among Nigerian female undergraduates, contributing to late detection — often only when infertility becomes an issue.
Cultural factors, including heavy reliance on faith-based solutions for health concerns and fragmented healthcare, exacerbate the problem. The new name equips women with stronger language to advocate for comprehensive testing: fasting insulin (not just blood sugar), full hormonal panels, metabolic screening, cardiovascular risk assessment, and mental health support.
What Nigerian Women Should Do Now
Existing diagnoses remain valid — but push for updated conversations with your doctor about metabolic and long-term risks.
Seek comprehensive evaluation if experiencing symptoms: irregular or absent periods, difficulty conceiving, stubborn weight issues, severe acne, or excessive hair growth.
Lifestyle measures like balanced diet, regular exercise, and weight management (even modest losses help) remain foundational, alongside potential medications like metformin for insulin resistance.
A 3-year global transition period is underway, so guidelines and awareness campaigns will evolve.
Health researcher and writer Jennifer Orisakwe, emphasized that this rename corrects a misleading label and could reduce years of silent suffering for Nigerian women.
This global update underscores a wider push for better women’s health recognition in Nigeria. As awareness grows, experts hope for earlier interventions, reduced infertility stigma, and fewer long-term complications.
Women are encouraged to consult qualified endocrinologists, gynecologists, or reproductive health specialists for personalized advice. Early action with PMOS can significantly improve quality of life and future health outcomes.
